Hematology
Deferasirox PSK
Registration certificate:
INN:
Deferasirox
Release form:
Таблетки диспергируемые
Терапевтическое направление:
Hematology
Фармакотерапевтическая группа:
Комплексообразующее средство
Conditions for dispensing:
On prescription
В упаковке:

Indications for Use:

Deferasirox PSC is intended for oral use and is indicated for the prevention and treatment of:

  • Chronic post-transfusion iron overload in adults and children aged 2 years and older.
  • Chronic post-transfusion iron overload in patients with thalassemia aged 10 years and older.

This medication is included in the List of Essential Medicines.

Quality control
at all stages of production